Cargando…
The spectraplakin Dystonin antagonizes YAP activity and suppresses tumourigenesis
Aberrant expression of the Spectraplakin Dystonin (DST) has been observed in various cancers, including those of the breast. However, little is known about its role in carcinogenesis. In this report, we demonstrate that Dystonin is a candidate tumour suppressor in breast cancer and provide an underl...
Autores principales: | Jain, Praachi B., Guerreiro, Patrícia S., Canato, Sara, Janody, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934804/ https://www.ncbi.nlm.nih.gov/pubmed/31882643 http://dx.doi.org/10.1038/s41598-019-56296-z |
Ejemplares similares
-
Role of Spectraplakin in Drosophila Photoreceptor Morphogenesis
por: Mui, Uyen Ngoc, et al.
Publicado: (2011) -
Activation of an actin signaling pathway in pre-malignant mammary epithelial cells by P-cadherin is essential for transformation
por: Faria, Lídia, et al.
Publicado: (2023) -
Spectraplakins: Master orchestrators of cytoskeletal dynamics
por: Suozzi, Kathleen C., et al.
Publicado: (2012) -
Isoforms, structures, and functions of versatile spectraplakin MACF1
por: Hu, Lifang, et al.
Publicado: (2016) -
Isoform-specific loss of dystonin causes hereditary motor and sensory neuropathy
por: Motley, William W., et al.
Publicado: (2020)